$36.70
-2.8%Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
Thin margins leave little room for error. Cost management and pricing strategy are critical.
Minimal operating profit suggests high operating costs or pricing challenges. Scalability is concerning.
Minimal profitability after all expenses. Limited financial flexibility for reinvestment or shareholder returns.
Higher tax burden may reflect limited tax optimization or operations in high-tax jurisdictions.
Efficient profit conversion: Minimal margin compression from gross to net indicates lean operations and favorable tax/interest environment.
ASTH โข NASDAQ
| Astrana Health, Inc. Income Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||
3.2B | 2B | 1.4B | 1.1B | 773.9M | 370.2M | 560.6M | 519.9M | 357.7M | 44M | |
GROSS PROFIT | ||||||||||
(2.9B) | (1.8B) | (1.2B) | (944.7M) | (596.1M) | (348.5M) | (467.8M) | (380.4M) | (293.7M) | (34.4M) | |
295.8M | 271.4M | 215M | 199.5M | 177.8M | 21.7M | 92.8M | 139.5M | 64M | 9.7M | |
OPERATING INCOME | ||||||||||
(217.3M) | (182M) | (130.3M) | (95.2M) | (79.6M) | (15.6M) | (60.4M) | (47.2M) | (26.4M) | (16.3M) | |
(217.3M) | (154.1M) | (112.6M) | (77.7M) | (62.1M) | (15.6M) | (41.5M) | (47.2M) | (26.4M) | (16.3M) | |
78.5M | 89.4M | 84.6M | 104.3M | 98.2M | 6.1M | 32.4M | 92.2M | 37.6M | -6.6M | |
PRE-TAX INCOME | ||||||||||
(49.9M) | (33.1M) | (16.1M) | (7.9M) | (5.4M) | (2.5M) | (4.7M) | (560.5K) | (79.7K) | (542.3K) | |
-37.8M | -18.6M | -1.9M | -5.9M | -3.8M | -2.1M | -2.7M | 698K | 935.5K | -542.3K | |
(0.0) | (27.9M) | (17.7M) | (17.5M) | (17.5M) | (26K) | (18.9M) | (0.0) | (0.0) | (0.0) | |
-38.9M | -8.5M | 5.2M | -17.6M | -20.4M | 2.8M | -6.6M | -9.6M | 12.1M | -1.7M | |
39.6M | 80.8M | 89.8M | 86.6M | 77.7M | 8.9M | 25.8M | 82.6M | 49.7M | -8.2M | |
NET INCOME | ||||||||||
(15.5M) | (30.9M) | (32M) | (40.9M) | (31.7M) | (9.2M) | (8.2M) | (22.4M) | (3.9M) | -71K | |
22.5M | 43.1M | 60.7M | 45.2M | 68.9M | -23.8M | 14.1M | 10.8M | 25.8M | -9.3M |
ASTH - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 12, 2026 | May 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 12, 2026 | May 07, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 08, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | April 17, 2026 | June 10, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 30, 2026 | March 30, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 12, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 04, 2026 | March 04, 2026 | 2026 | |
8-K 8-K 2026 N/A | March 02, 2026 | March 02, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 12, 2026 | January 12, 2026 | 2026 |
Continue your ASTH research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.